A citation-based method for searching scientific literature

Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, Yazhou Li, David Tweedie, Maja Mustapic, Sahil Chawla, Kashfia Chowdhury, Simon S Skene, Nigel H Greig, Dimitrios Kapogiannis, Thomas Foltynie. JAMA Neurol 2019
Times Cited: 97







List of co-cited articles
1377 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
342
45

Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
281
28

Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes.
Maja Mustapic, Erez Eitan, John K Werner, Sean T Berkowitz, Michael P Lazaropoulos, Joyce Tran, Edward J Goetzl, Dimitrios Kapogiannis. Front Neurosci 2017
201
26


Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Parkinsons Dis 2014
163
23

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
405
23

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.
Massimo S Fiandaca, Dimitrios Kapogiannis, Mark Mapstone, Adam Boxer, Erez Eitan, Janice B Schwartz, Erin L Abner, Ronald C Petersen, Howard J Federoff, Bruce L Miller,[...]. Alzheimers Dement 2015
472
20

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.
Seung Pil Yun, Tae-In Kam, Nikhil Panicker, SangMin Kim, Yumin Oh, Jong-Sung Park, Seung-Hwan Kwon, Yong Joo Park, Senthilkumar S Karuppagounder, Hyejin Park,[...]. Nat Med 2018
415
20

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm,[...]. J Neurosci Res 2008
241
19

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.
Dimitrios Kapogiannis, Adam Boxer, Janice B Schwartz, Erin L Abner, Arya Biragyn, Umesh Masharani, Lynda Frassetto, Ronald C Petersen, Bruce L Miller, Edward J Goetzl. FASEB J 2015
211
18

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.
Edward J Goetzl, Adam Boxer, Janice B Schwartz, Erin L Abner, Ronald C Petersen, Bruce L Miller, Dimitrios Kapogiannis. Neurology 2015
256
17



Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
Alexander Harkavyi, Amjad Abuirmeileh, Rebecca Lever, Ann E Kingsbury, Christopher S Biggs, Peter S Whitton. J Neuroinflammation 2008
191
16

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.
Min Shi, Changqin Liu, Travis J Cook, Kristin M Bullock, Yanchun Zhao, Carmen Ginghina, Yanfei Li, Patrick Aro, Romel Dator, Chunmei He,[...]. Acta Neuropathol 2014
334
16


A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
Ziyue Yuan, Dongfang Li, Peng Feng, Guofang Xue, Chenhui Ji, Guanglai Li, Christian Hölscher. Eur J Pharmacol 2017
53
30

Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.
Edward J Goetzl, Dimitrios Kapogiannis, Janice B Schwartz, Iryna V Lobach, Laura Goetzl, Erin L Abner, Gregory A Jicha, Anna M Karydas, Adam Boxer, Bruce L Miller. FASEB J 2016
199
15

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
15


A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
Chenhui Ji, Guo-Fang Xue, Cao Lijun, Peng Feng, Dongfang Li, Lin Li, Guanglai Li, Christian Hölscher. Brain Res 2016
62
22

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.
Peng Feng, Xiangjian Zhang, Dongfang Li, Chenhui Ji, Ziyue Yuan, Ruifang Wang, Guofang Xue, Guanglai Li, Christian Hölscher. Neuropharmacology 2018
54
24

In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Michael Gejl, Albert Gjedde, Lærke Egefjord, Arne Møller, Søren B Hansen, Kim Vang, Anders Rodell, Hans Brændgaard, Hanne Gottrup, Anna Schacht,[...]. Front Aging Neurosci 2016
208
13

Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging.
Dimitrios Kapogiannis, Maja Mustapic, Michelle D Shardell, Sean T Berkowitz, Thomas C Diehl, Ryan D Spangler, Joyce Tran, Michael P Lazaropoulos, Sahil Chawla, Seema Gulyani,[...]. JAMA Neurol 2019
90
14

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
13

Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.
Roger J Mullins, Maja Mustapic, Edward J Goetzl, Dimitrios Kapogiannis. Hum Brain Mapp 2017
74
16

Low neural exosomal levels of cellular survival factors in Alzheimer's disease.
Edward J Goetzl, Adam Boxer, Janice B Schwartz, Erin L Abner, Ronald C Petersen, Bruce L Miller, Olga D Carlson, Maja Mustapic, Dimitrios Kapogiannis. Ann Clin Transl Neurol 2015
120
12

Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver,[...]. Sci Transl Med 2013
321
12


A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
Dong Seok Kim, Ho-Il Choi, Yun Wang, Yu Luo, Barry J Hoffer, Nigel H Greig. Cell Transplant 2017
72
16

Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
Maja Mustapic, Joyce Tran, Suzanne Craft, Dimitrios Kapogiannis. J Alzheimers Dis 2019
30
40

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.
Clotilde Théry, Kenneth W Witwer, Elena Aikawa, Maria Jose Alcaraz, Johnathon D Anderson, Ramaroson Andriantsitohaina, Anna Antoniou, Tanina Arab, Fabienne Archer, Georgia K Atkin-Smith,[...]. J Extracell Vesicles 2018
12

Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson's Disease.
Zhen-Hua Zhao, Zhi-Ting Chen, Rui-Ling Zhou, Xu Zhang, Qin-Yong Ye, Yin-Zhou Wang. Front Aging Neurosci 2019
66
18

Extracellular vesicles: exosomes, microvesicles, and friends.
Graça Raposo, Willem Stoorvogel. J Cell Biol 2013
11

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Li-Ying Han, Kalindi P Bakshi, Andres Stucky, Robert L Fuino, Krista R Kawaguchi, Andrew J Samoyedny, Robert S Wilson,[...]. J Clin Invest 2012
11

Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease.
Edward J Goetzl, Erin L Abner, Gregory A Jicha, Dimitrios Kapogiannis, Janice B Schwartz. FASEB J 2018
106
11


Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease.
Shuchun Chen, Seong-Jin Yu, Yazhou Li, Daniela Lecca, Elliot Glotfelty, Hee Kyung Kim, Ho-Il Choi, Barry J Hoffer, Nigel H Greig, Dong Seok Kim,[...]. Sci Rep 2018
29
37

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
138
11

Exosomes are released by cultured cortical neurones.
J Fauré, G Lachenal, M Court, J Hirrlinger, C Chatellard-Causse, B Blot, J Grange, G Schoehn, Y Goldberg, V Boyer,[...]. Mol Cell Neurosci 2006
567
11


Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher. Neuropharmacology 2016
51
21

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.
Steven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, Aaron M Koenig, Hoau-Yan Wang, Rexford S Ahima, Suzanne Craft, Sam Gandy, Christoph Buettner, Luke E Stoeckel,[...]. Nat Rev Neurol 2018
513
11

Post hoc analysis of the Exenatide-PD trial-Factors that predict response.
Dilan Athauda, Kate Maclagan, Natalia Budnik, Luca Zampedri, Steve Hibbert, Iciar Aviles-Olmos, Kashfia Chowdhury, Simon S Skene, Patricia Limousin, Thomas Foltynie. Eur J Neurosci 2019
29
37

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.
Kenneth W Witwer, Edit I Buzás, Lynne T Bemis, Adriana Bora, Cecilia Lässer, Jan Lötvall, Esther N Nolte-'t Hoen, Melissa G Piper, Sarada Sivaraman, Johan Skog,[...]. J Extracell Vesicles 2013
10

Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.
Edward J Goetzl, Maja Mustapic, Dimitrios Kapogiannis, Erez Eitan, Irina V Lobach, Laura Goetzl, Janice B Schwartz, Bruce L Miller. FASEB J 2016
179
10

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.
Lijun Cao, Dongfang Li, Peng Feng, Lin Li, Guo-Fang Xue, Guanglai Li, Christian Hölscher. Neuroreport 2016
50
20

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.
Lydia Alvarez-Erviti, Yiqi Seow, Anthony H Schapira, Chris Gardiner, Ian L Sargent, Matthew J A Wood, J Mark Cooper. Neurobiol Dis 2011
466
10

Exosomal cell-to-cell transmission of alpha synuclein oligomers.
Karin M Danzer, Lisa R Kranich, Wolfgang P Ruf, Ozge Cagsal-Getkin, Ashley R Winslow, Liya Zhu, Charles R Vanderburg, Pamela J McLean. Mol Neurodegener 2012
533
10

Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.
Longfei Jia, Qiongqiong Qiu, Heng Zhang, Lan Chu, Yifeng Du, Jiewen Zhang, Chunkui Zhou, Furu Liang, Shengliang Shi, Shan Wang,[...]. Alzheimers Dement 2019
118
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.